CD8A and lymphoma: In E.G7-OVA lymphoma model, OVA tumor antigens-specific tetramer+CD8+ T cells have also been analyzed, and the results suggest that FeMOF-based cancer vaccines resulted in the increase in tumor antigens-specific CD8+ T cells populations.